The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
Therapeutic targeting of EPH receptors and their ligands
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Wang, H. U., Chen, Z.-F., & Anderson, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81436-1 · Cited by 1,669
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
Wang, Y., Nakayama, M., Pitulescu, M. E., Schmidt, T. S., Bochenek, M. L., Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lüthi, U., et al. (2010) · Nature · doi:10.1038/nature09002 · Cited by 1,271
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Pasquale, E. B. (2008) · Cell · doi:10.1016/j.cell.2008.03.011 · Cited by 1,252
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M. W., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01015-2 · Cited by 1,120
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W., & Klein, R. (1999) · Genes & Development · doi:10.1101/gad.13.3.295 · Cited by 1,025
Merlos-Suárez, A., Barriga, F. M., Jung, P., Iglesias, M., Céspedes, M. V., Rossell, D., Sevillano, M., Hernando-Momblona, X., da Silva-Diz, V., Muñoz, P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.02.020 · Cited by 934
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.012 · Cited by 777
Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., Pawson, T., Goldfarb, M., & Yancopoulos, G. D. (1994) · Science · doi:10.1126/science.7973638 · Cited by 710
Isolation and in vitro expansion of human colonic stem cells
Jung, P., Sato, T., Merlos-Suárez, A., Barriga, F. M., Iglesias, M., Rossell, D., Auer, H., Gallardo, M., Blasco, M. A., Sancho, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2470 · Cited by 709
Gerety, S. S., Wang, H. U., Chen, Z.-F., & Anderson, D. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80342-1 · Cited by 707
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., & Lee, B. (2005) · Nature · doi:10.1038/nature03838 · Cited by 570
Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T. E., Mintz, A. H., Engh, J. A., Bartlett, D. L., Brown, C. K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7744 · Cited by 567
Miao, H., Burnett, E., Kinch, M., Simon, E., & Wang, B. (2000) · Nature Cell Biology · doi:10.1038/35000008 · Cited by 548
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker-Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 534
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.009 · Cited by 533
Regulated Cleavage of a Contact-Mediated Axon Repellent
Hattori, M., Osterfield, M., & Flanagan, J. G. (2000) · Science · doi:10.1126/science.289.5483.1360 · Cited by 518
Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands
Holland, S. J., Gale, N. W., Mbamalu, G., Yancopoulos, G. D., Henkemeyer, M., & Pawson, T. (1996) · Nature · doi:10.1038/383722a0 · Cited by 516
Conover, J. C., Doetsch, F., Garcia-Verdugo, J.-M., Gale, N. W., Yancopoulos, G. D., & Alvarez-Buylla, A. (2000) · Nature Neuroscience · doi:10.1038/80606 · Cited by 481
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
Bonaparte, M. I., Dimitrov, A. S., Bossart, K. N., Crameri, G., Mungall, B. A., Bishop, K. A., Choudhry, V., Dimitrov, D. S., Wang, L.-F., Eaton, B. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504887102 · Cited by 479
Eph receptors and ephrins restrict cell intermingling and communication
Mellitzer, G., Xu, Q., & Wilkinson, D. G. (1999) · Nature · doi:10.1038/21907 · Cited by 474
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
Mäkinen, T., Adams, R. H., Bailey, J., Lu, Q., Ziemiecki, A., Alitalo, K., Klein, R., & Wilkinson, G. A. (2005) · Genes & Development · doi:10.1101/gad.330105 · Cited by 461
Janes, P. W., Saha, N., Barton, W. A., Kolev, M. V., Wimmer-Kleikamp, S. H., Nievergall, E., Blobel, C. P., Himanen, J.-P., Lackmann, M., & Nikolov, D. B. (2005) · Cell · doi:10.1016/j.cell.2005.08.014 · Cited by 443
Self-citationEphrin-B2 Controls Cell Motility and Adhesion during Blood-Vessel-Wall Assembly
Foo, S. S., Turner, C. J., Adams, S., Compagni, A., Aubyn, D., Kogata, N., Lindblom, P., Shani, M., Zicha, D., & Adams, R. H. (2006) · Cell · doi:10.1016/j.cell.2005.10.034 · Cited by 441
Diverse Roles of Eph Receptors and Ephrins in the Regulation of Cell Migration and Tissue Assembly
Poliakov, A., Cotrina, M., & Wilkinson, D. G. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.006 · Cited by 436
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
Cai, W., Chen, K., Li, Z.-B., Gambhir, S. S., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043216 · Cited by 429
Bidirectional modulation of synaptic functions by Eph/ephrin signaling
Klein, R. (2009) · Nature Neuroscience · doi:10.1038/nn.2231 · Cited by 423
EphB receptor activity suppresses colorectal cancer progression
Batlle, E., Bacani, J., Begthel, H., Jonkeer, S., Gregorieff, A., van de Born, M., Malats, N., Sancho, E., Boon, E., Pawson, T., et al. (2005) · Nature · doi:10.1038/nature03626 · Cited by 413
Axon Guidance Molecules in Vascular Patterning
Adams, R. H., & Eichmann, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001875 · Cited by 405
Bidirectional Eph–ephrin signaling during axon guidance
Egea, J., & Klein, R. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.03.004 · Cited by 393
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
Lu, Q., Sun, E. E., Klein, R. S., & Flanagan, J. G. (2001) · Cell · doi:10.1016/s0092-8674(01)00297-5 · Cited by 376
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Miao, H., Wei, B.-R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., & Wang, B. (2001) · Nature Cell Biology · doi:10.1038/35074604 · Cited by 358
Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., & Clark, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3633 · Cited by 344
Bundesen, L. Q., Scheel, T. A., Bregman, B. S., & Kromer, L. F. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07789.2003 · Cited by 344
Twigg, S. R. F., Kan, R., Babbs, C., Bochukova, E. G., Robertson, S. P., Wall, S. A., Morriss-Kay, G. M., & Wilkie, A. O. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402819101 · Cited by 343
Crystal structure of an Eph receptor–ephrin complex
Himanen, J.-P., Rajashankar, K. R., Lackmann, M., Cowan, C. A., Henkemeyer, M., & Nikolov, D. B. (2001) · Nature · doi:10.1038/414933a · Cited by 339
Self-citationRegulation of repulsion versus adhesion by different splice forms of an Eph receptor
Holmberg, J., Clarke, D. L., & Frisén, J. (2000) · Nature · doi:10.1038/35041577 · Cited by 334
Restriction of Receptor Movement Alters Cellular Response: Physical Force Sensing by EphA2
Salaita, K., Nair, P. M., Petit, R. S., Neve, R. M., Das, D., Gray, J. W., & Groves, J. T. (2010) · Science · doi:10.1126/science.1181729 · Cited by 331
Role of EphA4 and EphrinB3 in Local Neuronal Circuits That Control Walking
Kullander, K., Butt, S. J. B., Lebret, J. M., Lundfald, L., Restrepo, C. E., Rydström, A., Klein, R., & Kiehn, O. (2003) · Science · doi:10.1126/science.1079641 · Cited by 330
The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals
Cowan, C. A., & Henkemeyer, M. (2001) · Nature · doi:10.1038/35093123 · Cited by 323
Axonal Regeneration and Lack of Astrocytic Gliosis in EphA4-Deficient Mice
Goldshmit, Y., Galea, M. P., Wise, G., Bartlett, P. F., & Turnley, A. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2981-04.2004 · Cited by 317
Self-citationEphB Receptors Coordinate Migration and Proliferation in the Intestinal Stem Cell Niche
Holmberg, J., Genander, M., Halford, M. M., Annerén, C., Sondell, M., Chumley, M. J., Silvany, R. E., Henkemeyer, M., & Frisén, J. (2006) · Cell · doi:10.1016/j.cell.2006.04.030 · Cited by 313
Kinase-Independent Requirement of EphB2 Receptors in Hippocampal Synaptic Plasticity
Grunwald, I. C., Korte, M., Wolfer, D., Wilkinson, G. A., Unsicker, K., Lipp, H.-P., Bonhoeffer, T., & Klein, R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00550-5 · Cited by 306
EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract
Dottori, M., Hartley, L., Galea, M., Paxinos, G., Polizzotto, M., Kilpatrick, T., Bartlett, P. F., Murphy, M., Köntgen, F., & Boyd, A. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13248 · Cited by 306
Self-citationEPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2901 · Cited by 303
Eph/ephrin signaling: networks
Arvanitis, D., & Davy, A. (2008) · Genes & Development · doi:10.1101/gad.1630408 · Cited by 303
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Wykosky, J., & Debinski, W. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0244 · Cited by 300
Davy, A., Gale, N. W., Murray, E. W., Klinghoffer, R. A., Soriano, P., Feuerstein, C., & Robbins, S. M. (1999) · Genes & Development · doi:10.1101/gad.13.23.3125 · Cited by 296
Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport
Filosa, A., Paixão, S., Honsek, S. D., Carmona, M. A., Becker, L., Feddersen, B., Gaitanos, L., Rudhard, Y., Schoepfer, R., Klopstock, T., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2394 · Cited by 289
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathway
Noren, N. K., Foos, G., Hauser, C. A., & Pasquale, E. B. (2006) · Nature Cell Biology · doi:10.1038/ncb1438 · Cited by 288
Ephrin-B1 forward and reverse signaling are required during mouse development
Davy, A., Aubin, J., & Soriano, P. (2004) · Genes & Development · doi:10.1101/gad.1171704 · Cited by 288
Ephrin signalling controls brain size by regulating apoptosis of neural progenitors
Depaepe, V., Suarez-Gonzalez, N., Dufour, A., Passante, L., Gorski, J. A., Jones, K. R., Ledent, C., & Vanderhaeghen, P. (2005) · Nature · doi:10.1038/nature03651 · Cited by 284
Brantley-Sieders, D. M., Zhuang, G., Hicks, D., Fang, W. B., Hwang, Y., Cates, J. M. M., Coffman, K., Jackson, D., Bruckheimer, E., Muraoka-Cook, R. S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33154 · Cited by 278
Eph/ephrin molecules—a hub for signaling and endocytosis
Pitulescu, M. E., & Adams, R. H. (2010) · Genes & Development · doi:10.1101/gad.1973910 · Cited by 276
EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells
Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernández-Masip, J. L., Vivancos, A., Whissell, G., Humà, M., Peiró, N., Gallego, L., Jonkheer, S., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.11 · Cited by 269
A conditional feedback loop regulates Ras activity through EphA2
Macrae, M., Neve, R. M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen, C., Gray, J. W., & McCormick, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.005 · Cited by 260
Architecture of Eph receptor clusters
Himanen, J. P., Yermekbayeva, L., Janes, P. W., Walker, J. R., Xu, K., Atapattu, L., Rajashankar, K. R., Mensinga, A., Lackmann, M., Nikolov, D. B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004148107 · Cited by 259
Self-citationKullander, K., Mather, N. K., Diella, F., Dottori, M., Boyd, A. W., & Klein, R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00181-7 · Cited by 258
Self-citationRegulation of Angiogenesis by Eph–Ephrin Interactions
Kuijper, S., Turner, C. J., & Adams, R. H. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.03.003 · Cited by 257
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M., & Pasquale, E. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401381101 · Cited by 245
Astin, J. W., Batson, J., Kadir, S., Charlet, J., Persad, R. A., Gillatt, D., Oxley, J. D., & Nobes, C. D. (2010) · Nature Cell Biology · doi:10.1038/ncb2122 · Cited by 245
Tsuda, H., Han, S. M., Yang, Y., Tong, C., Lin, Y. Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.039 · Cited by 242
Ashida, S., Nakagawa, H., Katagiri, T., Furihata, M., Iiizumi, M., Anazawa, Y., Tsunoda, T., Takata, R., Kasahara, K., Miki, T., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0020 · Cited by 238
Eph/Ephrin Signaling in Injury and Inflammation
Coulthard, M. G., Morgan, M., Woodruff, T. M., Arumugam, T. V., Taylor, S. M., Carpenter, T. C., Lackmann, M., & Boyd, A. W. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.06.043 · Cited by 234
Self-citationControl of Skeletal Patterning by EphrinB1-EphB Interactions
Compagni, A., Logan, M., Klein, R., & Adams, R. H. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00198-9 · Cited by 231
Jørgensen, C., Sherman, A., Chen, G. I., Pasculescu, A., Poliakov, A., Hsiung, M., Larsen, B., Wilkinson, D. G., Linding, R., & Pawson, T. (2009) · Science · doi:10.1126/science.1176615 · Cited by 226
An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly
Seiradake, E., Harlos, K., Sutton, G., Aricescu, A. R., & Jones, E. Y. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1782 · Cited by 222
Binda, E., Visioli, A., Giani, F., Lamorte, G., Copetti, M., Pitter, K. L., Huse, J. T., Cajola, L., Zanetti, N., DiMeco, F., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.005 · Cited by 220
EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
Day, B. W., Stringer, B. W., Al-Ejeh, F., Ting, M. J., Wilson, J., Ensbey, K. S., Jamieson, P. R., Bruce, Z. C., Lim, Y. C., Offenhäuser, C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.007 · Cited by 218
Self-citationEphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Thaker, P. H., Deavers, M., Celestino, J., Thornton, A., Fletcher, M. S., Landen, C. N., Kinch, M. S., Kiener, P. A., & Sood, A. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0589 · Cited by 211
Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis
Holmberg, J., Armulik, A., Senti, K.-A., Edoff, K., Spalding, K., Momma, S., Cassidy, R., Flanagan, J. G., & Frisén, J. (2005) · Genes & Development · doi:10.1101/gad.326905 · Cited by 209
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Zhuang, G., Brantley-Sieders, D. M., Vaught, D., Yu, J., Xie, L., Wells, S., Jackson, D., Muraoka-Cook, R., Arteaga, C., & Chen, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1845 · Cited by 208
Ephrin signaling in vivo: Look both ways
Davy, A., & Soriano, P. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20200 · Cited by 207
Brantley-Sieders, D. M., Caughron, J., Hicks, D., Pozzi, A., Ruiz, J. C., & Chen, J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01061 · Cited by 203
p75NTR Mediates Ephrin-A Reverse Signaling Required for Axon Repulsion and Mapping
Lim, Y.-S., McLaughlin, T., Sung, T.-C., Santiago, A., Lee, K.-F., & O'Leary, D. D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.032 · Cited by 202
Huang, J., Xiao, D., Li, G., Ma, J., Chen, P., Yuan, W., Hou, F., Ge, J., Zhong, M., Tang, Y., et al. (2014) · Oncogene · doi:10.1038/onc.2013.238 · Cited by 200
Neuropsin cleaves EphB2 in the amygdala to control anxiety
Attwood, B. K., Bourgognon, J.-M., Patel, S., Mucha, M., Schiavon, E., Skrzypiec, A. E., Young, K. W., Shiosaka, S., Korostynski, M., Piechota, M., et al. (2011) · Nature · doi:10.1038/nature09938 · Cited by 200
EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts
Allan, E. H., Häusler, K. D., Wei, T., Gooi, J. H., Quinn, J. M., Crimeen-Irwin, B., Pompolo, S., Sims, N. A., Gillespie, M. T., Onyia, J. E., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080324 · Cited by 199
Hansen, M. J., Dallal, G. E., & Flanagan, J. G. (2004) · Neuron · doi:10.1016/j.neuron.2004.05.009 · Cited by 196
Molecular Mechanisms of Cell Segregation and Boundary Formation in Development and Tumorigenesis
Batlle, E., & Wilkinson, D. G. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008227 · Cited by 196
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Carles‐Kinch, K., Kilpatrick, K. E., Stewart, J. C., & Kinch, M. S. (2002) · PubMed · Cited by 195
Birgbauer, E., Cowan, C. A., Sretavan, D. W., & Henkemeyer, M. (2000) · Development · doi:10.1242/dev.127.6.1231 · Cited by 195
Neural map specification by gradients
Flanagan, J. G. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.01.010 · Cited by 193
Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer
Kumar, S. R., Singh, J., Xia, G., Krasnoperov, V., Hassanieh, L., Ley, E. J., Scehnet, J., Kumar, N. G., Hawes, D., Press, M. F., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050889 · Cited by 191
An efficient rapid system for profiling the cellular activities of molecular libraries
Melnick, J. S., Janes, J., Kim, S., Chang, J. Y., Sipes, D. G., Gunderson, D., Jarnes, L., Matzen, J. T., Garcia, M. E., Hood, T. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511292103 · Cited by 186
EphrinA1-induced cytoskeletal re-organization requires FAK and p130cas
Carter, N., Nakamoto, T., Hirai, H., & Hunter, T. (2002) · Nature Cell Biology · doi:10.1038/ncb823 · Cited by 186
Silencing of EphA3 through a cis interaction with ephrinA5
Carvalho, R. F., Beutler, M., Marler, K. J. M., Knöll, B., Becker-Barroso, E., Heintzmann, R., Ng, T., & Drescher, U. (2006) · Nature Neuroscience · doi:10.1038/nn1655 · Cited by 182
EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics
Ireton, R., & Chen, J. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765780 · Cited by 178
Genander, M., Halford, M. M., Xu, N.-J., Eriksson, M., Yu, Z., Qiu, Z., Martling, A., Greicius, G., Thakar, S., Catchpole, T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.08.048 · Cited by 178
Hochgräfe, F., Zhang, L., O'Toole, S. A., Browne, B. C., Pinese, M., Porta Cubas, A., Lehrbach, G. M., Croucher, D. R., Rickwood, D., Boulghourjian, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0911 · Cited by 175
Holzman, L. B., Marks, R. M., & Dixit, V. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5830 · Cited by 172
The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma
Oricchio, E., Nanjangud, G., Wolfe, A. L., Schatz, J. H., Mavrakis, K. J., Jiang, M., Liu, X., Bruno, J., Heguy, A., Olshen, A. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.035 · Cited by 172
Roles of Eph receptors and ephrins in the normal and damaged adult CNS
Goldshmit, Y., McLenachan, S., & Turnley, A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.006 · Cited by 171
Lawrenson, I. D., Wimmer-Kleikamp, S. H., Lock, P., Schoenwaelder, S. M., Down, M., Boyd, A. W., Alewood, P. F., & Lackmann, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.1059 · Cited by 169
Self-citationBone cell interactions through Eph/ephrin: Bone modeling, remodeling and associated diseases
Matsuo, K., & Otaki, N. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20888 · Cited by 167
Kertesz, N., Krasnoperov, V., Reddy, R., Leshanski, L., Kumar, S. R., Zozulya, S., & Gill, P. S. (2006) · Blood · doi:10.1182/blood-2005-04-1655 · Cited by 164
Lin, L., Lesnick, T. G., Maraganore, D. M., & Isacson, O. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.006 · Cited by 164
Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling
Solanas, G., Cortina, C., Sevillano, M., & Batlle, E. (2011) · Nature Cell Biology · doi:10.1038/ncb2298 · Cited by 162
Balakrishnan, A., Bleeker, F. E., Lamba, S., Rodolfo, M., Daniotti, M., Scarpa, A., van Tilborg, A. A., Leenstra, S., Zanon, C., & Bardelli, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0065 · Cited by 161
Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist
Dobrzanski, P., Hunter, K., Jones-Bolin, S., Chang, H., Robinson, C., Pritchard, S., Zhao, H., & Ruggeri, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3430-2 · Cited by 160
Georgakopoulos, A., Litterst, C., Ghersi, E., Baki, L., Xu, C., Serban, G., & Robakis, N. K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601031 · Cited by 160
A phase 2 trial of dasatinib in advanced melanoma
Kluger, H. M., Dudek, A. Z., McCann, C., Ritacco, J., Southard, N. Z., Jilaveanu, L. B., Molinaro, A. M., & Sznol, M. (2010) · Cancer · doi:10.1002/cncr.25766 · Cited by 160
Eph Receptors and Ephrin Ligands Essential Mediators of Vascular Development
Adams, R. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00046-3 · Cited by 159
Chang, Q., Jorgensen, C., Pawson, T., & Hedley, D. W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604676 · Cited by 158
Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning
Xu, N.-J., & Henkemeyer, M. (2009) · Nature Neuroscience · doi:10.1038/nn.2254 · Cited by 158
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis
Erber, R., Eichelsbacher, U., Powajbo, V., Korn, T., Djonov, V., Lin, J., Hammes, H., Grobholz, R., Ullrich, A., & Vajkoczy, P. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600949 · Cited by 158
Davy, A., Bush, J. O., & Soriano, P. M. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040315 · Cited by 157
Ephrins and Eph receptors in stem cells and cancer
Genander, M., & Frisén, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.005 · Cited by 154
Prévost, N., Woulfe, D. S., Jiang, H., Stalker, T. J., Marchese, P., Ruggeri, Z. M., & Brass, L. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404065102 · Cited by 153
A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor GrowthIn vivo
Jackson, D., Gooya, J. M., Mao, S., Kinneer, K., XU, L. L., Camara, M., Fazenbaker, C. A., Fleming, R. L., Swamynathan, S., Meyer, D. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1933 · Cited by 151
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?
Lackmann, M., & Boyd, A. (2008) · Science Signaling · doi:10.1126/stke.115re2 · Cited by 150
Self-citationEssential Roles of EphB Receptors and EphrinB Ligands in Endothelial Cell Function and Angiogenesis
Salvucci, O., & Tosato, G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-386503-8.00002-8 · Cited by 149
c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.
Walker‐Daniels, J., Riese, D. J., & Kinch, M. S. (2002) · PubMed · Cited by 149
Hunter, S., Zhuang, G., Brantley‐Sieders, D. M., Swat, W., Cowan, C. W., & Chen, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02215-05 · Cited by 148
EphB4 Expression and Biological Significance in Prostate Cancer
Xia, G., Kumar, S. R., Masood, R., Zhu, S., Reddy, R., Krasnoperov, V. G., Quinn, D. I., Henshall, S. M., Sutherland, R. L., Pinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2667 · Cited by 147
Foubert, P., Silvestre, J., Souttou, B., Barateau, V., Martin, C., Ebrahimian, T. G., Déan, C., Contreres, J. O., Sulpice, E., Levy, B. I., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28338 · Cited by 146
Wykosky, J., Palma, E., Gibo, D. M., Ringler, S. L., Turner, C. P., & Debinski, W. (2008) · Oncogene · doi:10.1038/onc.2008.328 · Cited by 144
Eph–ephrin signalling in adult tissues and cancer
Merlos‐Suárez, A., & Batlle, E. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.011 · Cited by 143
Chumley, M. J., Catchpole, T., Silvany, R. E., Kernie, S. G., & Henkemeyer, M. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4158-07.2007 · Cited by 142
Guo, H., Miao, H., Gerber, L., Singh, J., Denning, M. F., Gilliam, A. C., & Wang, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0004 · Cited by 139
Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression
Kumar, S. R., Scehnet, J. S., Ley, E. J., Singh, J., Krasnoperov, V. G., Liu, R., Manchanda, P. K., Ladner, R. D., Hawes, D., Weaver, F. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3232 · Cited by 138
Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors
Noberini, R., Koolpe, M., Peddibhotla, S., Dahl, R. S., Su, Y., Cosford, N. D. P., Roth, G. P., & Pasquale, E. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804103200 · Cited by 137
Kao, T., & Kania, A. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.031 · Cited by 136
Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer
Landen, C. N., Lu, C., Han, L. Y., Coffman, K. T., Bruckheimer, E., Halder, J., Mangala, L. S., Merritt, W. M., Lin, Y. G., Gao, C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj414 · Cited by 136
Hypoxia up‐regulates expression of Eph receptors and ephrins in mouse skin
Vihanto, M. M., Plock, J. A., Erni, D., Frey, B. M., Frey, F. J., & Huynh‐Do, U. (2005) · The FASEB Journal · doi:10.1096/fj.04-3647fje · Cited by 134
Brantley‐Sieders, D. M., Jiang, A., Sarma, K., Badu-Nkansah, A., Walter, D. L., Shyr, Y., & Chen, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024426 · Cited by 134
Paradoxes of the EphB4 Receptor in Cancer
Hooten, N. N., & Pasquale, E. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0525 · Cited by 132
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
Martiny‐Baron, G., Holzer, P., Billy, É., Schnell, C., Brueggen, J., Ferretti, M., Schmiedeberg, N., Wood, J. M., Furet, P., & Imbach, P. A. (2010) · Angiogenesis · doi:10.1007/s10456-010-9183-z · Cited by 132
Inhibition of Tumor Growth and Angiogenesis by Soluble EphB4
Martiny‐Baron, G., Korff, T., Schaffner, F., Esser, N., Eggstein, S., Marmé, D., & Augustin, H. G. (2004) · Neoplasia · doi:10.1593/neo.03457 · Cited by 132
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
Fang, W. B., Ireton, R. C., Zhuang, G., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.017145 · Cited by 129
Brantley‐Sieders, D. M., Fang, W. B., Hicks, D. J., Zhuang, G., Shyr, Y., & Chen, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4038fje · Cited by 129
Parri, M., Taddei, M. L., Bianchini, F., Calorini, L., & Chiarugi, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1845 · Cited by 128
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis
Fang, W. B., Brantley‐Sieders, D. M., Parker, M. A., Reith, A. D., & Chen, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208937 · Cited by 127
EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer
Mao, W., Luis, E., Ross, S., Silva, J., Tan, C., Crowley, C. W., Chui, C. H., Franz, G., Senter, P. D., Koeppen, H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1047 · Cited by 127
EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway
Deroanne, C., Vouret‐Craviari, V., Wang, B., & Pouysségur, J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00308 · Cited by 126
Litterst, C. M., Georgakopoulos, A., Shioi, J., Ghersi, E., Wısnıewskı, T., Wang, R., Ludwig, A., & Robakis, N. K. R. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611449200 · Cited by 122
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
Annunziata, C. M., Kohn, E. C., LoRusso, P. M., Houston, N. D., Coleman, R. L., Buzoianu, M., Robbie, G. J., & Lechleider, R. J. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9801-2 · Cited by 121
Goldshmit, Y., Spanevello, M., Tajouri, S., Li, L., Rogers, F., Pearse, M. J., Galea, M. P., Bartlett, P. F., Boyd, A., & Turnley, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024636 · Cited by 120
Self-citationIntraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer
Landen, C. N., Merritt, W. M., Mangala, L. S., Sanguino, A. M., Bucana, C. D., Lü, C., Lin, Y. G., Han, L. Y., Kamat, A. A., Schmandt, R. E., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3468 · Cited by 119
Synaptic activity prompts γ-secretase–mediated cleavage of EphA4 and dendritic spine formation
Inoue, E., Deguchi‐Tawarada, M., Togawa, A., Matsui, C., Arita, K., Katahira-Tayama, S., Sato, T., Yamauchi, E., Oda, Y., & Takai, Y. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200809151 · Cited by 118
Eph receptors and ephrins in neuron–astrocyte communication at synapses
Murai, K. K., & Pasquale, E. B. (2011) · Glia · doi:10.1002/glia.21226 · Cited by 118
Chiari, R., Hames, G., Stroobant, V., Texier, C., Maillère, B., Boon, T., & Coulie, P. G. (2000) · PubMed · Cited by 117
Fabes, J., Anderson, P. N., Brennan, C. H., & Bolsover, S. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05859.x · Cited by 116
A relative signalling model for the formation of a topographic neural map
Reber, M., Burrola, P., & Lemke, G. (2004) · Nature · doi:10.1038/nature02957 · Cited by 116
Simón, A. M., de Maturana, R. L., Ricobaraza, A., Escribano, L., Schiapparelli, L., Cuadrado‐Tejedor, M., Pérez‐Mediavilla, A., Ávila, J., Río, J. D., & Frechilla, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1096 · Cited by 115
Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors
Choi, Y., Syeda, F., Walker, J. R., Finerty, P. J., Cuerrier, D., Wojciechowski, A., Liu, Q., Dhe‐Paganon, S., & Gray, N. S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.029 · Cited by 112
EphB2 is a Prognostic Factor in Colorectal Cancer
Jubb, A. M., Zhong, F., Bheddah, S., Grabsch, H. I., Frantz, G. D., Mueller, W., Kavi, V., Quirke, P., Polakis, P. G., & Koeppen, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0143 · Cited by 111
Expression of Ephb2 and Ephb4 in breast carcinoma
Wu, Q., Suo, Z., Risberg, B. Å., et al. (2004) · Pathology & Oncology Research · doi:10.1007/bf02893405 · Cited by 110
Abengózar, M. Á., de Frutos, S., Ferreiro, S., Soriano, J., Pérez‐Martínez, M., Olmeda, D., Marenchino, M., Cañamero, M., Ortega, S., Megı́as, D., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380006 · Cited by 108
Salvucci, O., Maric, D., Economopoulou, M., Sakakibara, S., Merlin, S., Follenzi, A., & Tosato, G. (2009) · Blood · doi:10.1182/blood-2008-12-192294 · Cited by 107
Downregulation of EphA7 by hypermethylation in colorectal cancer
Wang, J., Kataoka, H., Suzuki, M., Sato, N., Nakamura, R., Tao, H., Maruyama, K., Isogaki, J., Kanaoka, S., Ihara, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208720 · Cited by 107
Funk, S. D., Yurdagul, A., Albert, P., Traylor, J. G., Jin, L. G., Chen, J., & Orr, A. W. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.242792 · Cited by 106
Dasatinib: An Anti-Tumour Agent via Src Inhibition
Gnoni, A., Marech, I., Silvestris, N., Vacca, A., & Lorusso, V. (2011) · Current Drug Targets · doi:10.2174/138945011794751591 · Cited by 105
Segregation of Axial Motor and Sensory Pathways via Heterotypic Trans-Axonal Signaling
Gallarda, B. W., Bonanomi, D., Müller, D., Brown, A. M., Alaynick, W. A., Andrews, S. E., Lemke, G., Pfaff, S. L., & Marquardt, T. (2008) · Science · doi:10.1126/science.1153758 · Cited by 103
Ji, X., Guo, L., Feng, Y., Zhao, J., Li, J., Sun, Z.-J., Shi, S., Deng, Y., Xu, J., Zhu, Y.-Q., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0717 · Cited by 103
Putative dual role of ephrin-Eph receptor interactions in inflammation
Ivanov, A. I., & Romanovsky, A. A. (2006) · IUBMB Life · doi:10.1080/15216540600756004 · Cited by 102
Bush, J. O., & Soriano, P. M. (2010) · Genes & Development · doi:10.1101/gad.1963210 · Cited by 101
Meima, L., Kljavin, I. J., Moran, P., Shih, A., Winslow, J. W., & Caras, I. W. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01365.x · Cited by 100
Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding
Bochenek, M. L., Dickinson, S., Astin, J. W., Adams, R. H., & Nobes, C. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.061903 · Cited by 100
Djokovic, D., Trindade, A., Gigante, J., Badenes, M., Silva, L., Liu, R., Li, X., Gong, M., Krasnoperov, V. G., Gill, P. S., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-641 · Cited by 99
EphB Signaling Controls Lineage Plasticity of Adult Neural Stem Cell Niche Cells
Nomura, T., Göritz, C., Catchpole, T., Henkemeyer, M. J., & Frisén, J. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.11.009 · Cited by 99
Sd, W., Rath, P., Lal, B., Richard, J.-P., Li, Y., Goodwin, C. R., Laterra, J., & Xia, S. (2012) · Oncogene · doi:10.1038/onc.2012.16 · Cited by 98
The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development
Niessen, K., Zhang, G., Ridgway, J. B., Chen, H., Kolumam, G., Siebel, C. W., & Yan, M. (2011) · Blood · doi:10.1182/blood-2010-11-319129 · Cited by 97
Concepts and consequences of Eph receptor clustering
Janes, P. W., Nievergall, E., & Lackmann, M. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.001 · Cited by 96
Self-citationEph-dependent cell-cell adhesion and segregation in development and cancer
Nievergall, E., Lackmann, M., & Janes, P. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0900-6 · Cited by 96
Self-citationSalvucci, O., Sierra, M. D. L. L., Martina, J. A., McCormick, P. J., & Tosato, G. (2006) · Blood · doi:10.1182/blood-2006-05-023341 · Cited by 96
Jiao, J., Feldheim, D. A., & Chen, D. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708861105 · Cited by 96
Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway
Poliakov, A., Cotrina, M. L., Pasini, A., & Wilkinson, D. G. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200807151 · Cited by 94
A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor–expressing tumor cells
Wykosky, J., Gibo, D. M., & Debinski, W. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0200 · Cited by 94
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
Janes, P. W., Griesshaber, B., Atapattu, L., Nievergall, E., Hii, L. L., Mensinga, A., Chheang, C., Day, B. W., Boyd, A., Bastiaens, P. I. H., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201104037 · Cited by 93
Self-citationEph receptors are negatively controlled by protein tyrosine phosphatase receptor type O
Shintani, T., Ihara, M., Sakuta, H., Takahashi, H., Watakabe, I., & Noda, M. (2006) · Nature Neuroscience · doi:10.1038/nn1697 · Cited by 92
Kuang, S.-Q., Bai, H., Fang, Z.-H., López, G., Yang, H., Tong, W., Wang, Z., & Garcia‐Manero, G. (2010) · Blood · doi:10.1182/blood-2009-05-222208 · Cited by 92
Mechanisms of Inactivation of the Receptor Tyrosine Kinase EPHB2 in Colorectal Tumors
Alazzouzi, H., Dávalos, V., Kokko, A., Domingo, E., Woerner, S. M., Wilson, A. J., Konrad, L., Laiho, P., Espín, E., Armengol, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2580 · Cited by 92
Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647
Gendreau, S. B., Ventura, R., Keast, P., Laird, A., Yakes, F. M., Zhang, W., Bentzien, F., Cancilla, B., Lutman, J., Chu, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2590 · Cited by 90
EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma
Lee, J., Han, H. D., Shahzad, M. M. K., Kim, S. W., Mangala, L. S., Nick, A. M., Lü, C., Langley, R. R., Schmandt, R. E., Kim, H., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp231 · Cited by 90
Boyd, A., Ward, L. D., Wicks, I. P., Simpson, R. J., Salvaris, E. J., Wilks, A. F., Welch, K., Loudovaris, M., Rockman, S. P., & Busmanis, I. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50725-6 · Cited by 89
Self-citationLithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
Giorgio, C., Mohamed, I. H., Flammini, L., Barocelli, E., Incerti, M., Lodola, A., & Tognolini, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018128 · Cited by 88
Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanismPreprint
Bush, J. O., & Soriano, P. M. (2009) · Genes & Development · doi:10.1101/gad.1807209 · Cited by 88
Novel EphB4 Monoclonal Antibodies Modulate Angiogenesis and Inhibit Tumor Growth
Krasnoperov, V. G., Kumar, S. R., Ley, E. J., Li, X., Scehnet, J. S., Liu, R., Zozulya, S., & Gill, P. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090755 · Cited by 85
Fabes, J., Anderson, P. N., Yáñez‐Muñoz, R. J., Thrasher, A. J., Brennan, C. H., & Bolsover, S. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04704.x · Cited by 84
Dottori, M., Down, M., Hüttmann, A., Fitzpatrick, D. R., & Boyd, A. (1999) · Blood · doi:10.1182/blood.v94.7.2477.419k13_2477_2486 · Cited by 81
Self-citationA critical role for the EphA3 receptor tyrosine kinase in heart development
Stephen, L. J., Fawkes, A. L., Verhoeve, A., Lemke, G., & Brown, A. M. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.058 · Cited by 81
Ganju, P., Shigemoto, K., Brennan, J., et al. (1994) · PubMed · Cited by 81
Theus, M. H., Ricard, J., Bethea, J. R., & Liebl, D. J. (2010) · Stem Cells · doi:10.1002/stem.449 · Cited by 80
Eph receptors at synapses: Implications in neurodegenerative diseases
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.016 · Cited by 80
Zhang, R., Xiong, C., Huang, M. L., Zhou, M., Huang, Q., Wen, X., Liang, D., & Li, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.070 · Cited by 78
Epha2 is a critical oncogene in melanoma
Udayakumar, D., Zhang, G., Zhang, J., Njauw, C.-N., Mróz, P., & Tsao, H. (2011) · Oncogene · doi:10.1038/onc.2011.210 · Cited by 78
Cytoplasmic Relaxation of Active Eph Controls Ephrin Shedding by ADAM10
Janes, P. W., Wimmer-Kleikamp, S. H., Frangakis, A. S., Treble, K., Griesshaber, B., Sabet, O., Grabenbauer, M., Ting, A. Y., Säftig, P., Bastiaens, P. I. H., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000215 · Cited by 78
Self-citationMyelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury
Duffy, P. J., Wang, X., Siegel, C. S., Tu, N. C.-Y., Henkemeyer, M. J., Cafferty, W. B. J., & Strittmatter, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113953109 · Cited by 77
Rix, U., Rix, L. L. R., Terker, A. S., Fernbach, N. V., Hantschel, O. D., Planyavsky, M., Breitwieser, F. P., Herrmann, H., Colinge, J., Bennett, K. L., et al. (2009) · Leukemia · doi:10.1038/leu.2009.228 · Cited by 77
Research works printed but not linked: 26
- Marquardt, T. et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 121, 127–139 (2005). · doi:10.1016/j.cell.2005.01.020
- Gu, C. & Park, S. The EphA8 receptor regulates integrin activity through p110γ phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol. Cell. Biol. 21, 4579–4597 (2001). · doi:10.1128/mcb.21.14.4579-4597.2001
- Wimmer-Kleikamp, S. H. et al. Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood 112, 721–732 (2008). · doi:10.1182/blood-2007-11-121681
- Dopeso, H. et al. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Cancer Res. 69, 7430–7438 (2009). · doi:10.1158/0008-5472.can-09-0706
- Hagey, A. et al. A recombinant antibody to EphA3 for the treatment of hematologic malignancies: research update and interim Phase 1 study results. Blood (ASH Annual Meeting Abstracts) 118, 4893 (2011).
- Dawson, D. W. et al. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene 26, 4243–4252 (2007). · doi:10.1038/sj.onc.1210211
- Wang, J. et al. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma. Hum. Pathol. 38, 1649–1656 (2007). · doi:10.1016/j.humpath.2007.01.030
- Guan, M., Xu, C., Zhang, F. & Ye, C. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features. Int. J. Cancer 124, 88–94 (2009). · doi:10.1002/ijc.23890
- Nievergall, E., Saunders, T. & Lackmann, M. Targeting of EPH receptor tyrosine kinases for anticancer therapy. Crit. Rev. Oncog. 17, 211–232 (2012). · doi:10.1615/critrevoncog.v17.i2.60
- Palath, V. et al. A recombinant antibody to EphA3 with pro-apoptotic and enhanced ADCC activity against various hematologic malignancies shows selective inhibition of colony formation from long-term culture-initiating cells (LTC-ICs) in primary leukemia samples. Blood (ASH Annual Meeting Abstracts) 116, 2897 (2010).
- Heroult, M. et al. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2. Mol. Cancer Res. 8, 1297–1309 (2010). · doi:10.1158/1541-7786.mcr-09-0453
- Scehnet, J. S. et al. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood 113, 254–263 (2009). · doi:10.1182/blood-2008-02-140020
- Noblitt, L. W., Bangari, D. S., Shukla, S., Mohammed, S. & Mittal, S. K. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy. Cancer Gene Ther. 12, 46–53 (2005). · doi:10.1038/sj.cgt.7700763
- Wakelee, H. A. et al. A phase I dose-escalation and pharmacokinetic (PK) study of a novel spectrum selective kinase inhibitor, XL647, in patients with advanced solid malignancies (ASM). J. Clin. Oncol. 24, Abstr. 3044 (2006). · doi:10.1200/jco.2006.24.18_suppl.3044
- Bardelle, C. et al. Inhibitors of the tyrosine kinase EphB4. Part 1: structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines. Bioorg. Med. Chem. Lett. 18, 2776–2780 (2008). · doi:10.1016/j.bmcl.2008.04.015
- Jin, M. et al. Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients. Cancer Sci. 99, 1656–1662 (2008). · doi:10.1111/j.1349-7006.2008.00866.x
- Irizarry-Ramirez, M. et al. Upregulation of EphA3 receptor after spinal cord injury. J. Neurotrauma 22, 929–935 (2005). · doi:10.1089/neu.2005.22.929
- Arocho, L. C. et al. Expression profile and role of EphrinA1 ligand after spinal cord injury. Cell. Mol. Neurobiol. 31, 1057–1069 (2011). · doi:10.1007/s10571-011-9705-2
- Lickliter, J. D., Smith, F. M., Olsson, J. E., Mackwell, K. L. & Boyd, A. W. Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. Proc. Natl Acad. Sci. USA 93, 145–150 (1996). · doi:10.1073/pnas.93.1.145
- Lazarova, P. et al. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int. J. Immunopathol. Pharmacol. 19, 49–56 (2006). · doi:10.1177/205873920601900105
- Luo, H., Yu, G., Tremblay, J. & Wu, J. EphB6-null mutation results in compromised T cell function. J. Clin. Invest. 114, 1762–1773 (2004). · doi:10.1172/jci21846
- Baldwin, C. et al. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. Am. J. Physiol. Renal Physiol. 291, F960–F971 (2006). · doi:10.1152/ajprenal.00020.2006
- Cercone, M. A., Schroeder, W., Schomberg, S. & Carpenter, T. C. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L856–L863 (2009). · doi:10.1152/ajplung.00118.2009
- Tournoij, E. et al. The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor. Platelets 23, 617–625 (2012). · doi:10.3109/09537104.2011.645924
- Hayashi, S., Asahara, T., Masuda, H., Isner, J. M. & Losordo, D. W. Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization. Circulation 111, 2210–2218 (2005). · doi:10.1161/01.cir.0000163566.07427.73
- Zhao, X. et al. Vaccines targeting tumor blood vessel antigens promote CD8+ T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice. J. Immunol. 188, 1782–1788 (2012). · doi:10.4049/jimmunol.1101644
Cited by
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
“Ephrin receptors are the largest family of receptor tyrosine kinases (Boyd et al., 2014).”
BackgroundMechanisms of ephrin–Eph signalling in development, physiology and disease
Kania, A., & Klein, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.16 · Cited by 643
Eph Receptors and Ephrins: Therapeutic Opportunities
Barquilla, A., & Pasquale, E. B. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140226 · Cited by 294
Barcoded viral tracing of single-cell interactions in central nervous system inflammation
Clark, I. C., Gutiérrez-Vázquez, C., Wheeler, M. A., Li, Z., Rothhammer, V., Linnerbauer, M., Sanmarco, L. M., Guo, L., Blain, M., Zandee, S. E. J., et al. (2021) · Science · doi:10.1126/science.abf1230 · Cited by 285
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Tarantino, P., Ricciuti, B., Pradhan, S. M., & Tolaney, S. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00783-w · Cited by 269
Metadata
- Authors
- Boyd, A. W., Bartlett, P. F., & Lackmann, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-12-31
- Volume
- 13
- Issue
- 1
- Pages
- 39-62
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2038385234
- Cited by
- 341
- References
- 279
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.